Providing the most stable crystalline form
We stand behind its industry expertise, platform, technologies, and screening workflows to provide you with the OptiForm® API guarantee. Bring us your compound, and we will identify the most stable crystalline form.
The OptiForm® API screening is also part of the integrated OptiForm® Solution Suite offering which is designed to efficiently and rapidly help solve complex bioavailability challenges for early stage molecules. OptiForm® Solution Suite matches the best formulation technologies to your molecule, and utilizes an accelerated parallel screening and development approach, based on rigorous science and best-in-class scientific expertise, all in 12 weeks! Learn more here.
- New API screening platform that will help you speed your development and optimization of drug molecules
- Developed and refined over the past ten years with GlaxoSmithKline
- High throughput platform for salt, crystal-form, and co-crystal screening
- Applied to more than 500 compounds, spanning from early-stage lead compounds through launched products
- Conducted by a team of diverse and experienced scientists
All of our sites are subject to annual review so we can remain in compliance with:
- Canadian HPB
- British MHRA
- European Community
- Brazilian authorities